BioSpace News Archive

John Reed, who for five years has led Roche’s Pharma Research and Early Development (pRED) research group, is stepping down for personal reasons.

Sanofi SA and Evotec AG have teamed up to form an infectious disease research and development program.

JW Therapeutics, a clinical stage biopharma company founded by Juno Therapeutics and WuXi AppTec Group, has closed a Series A financing worth $90 million.

This week Pfizer notified the Bay Area-based company of its intent to terminate its five-year-old oncology collaboration.

Merck and Tokyo-based Eisai Co. have signed a strategic collaboration deal to develop and commercialize Lenvima with Merck’s anti-PD-1 drug Keytruda.

Cyteir Therapeutics snagged $29 million and a new chief executive officer as the company pushes forward to develop small-molecule inhibitors in the fight against cancer.

Seven months after Prevail Therapeutics launched, the company has secured $75 million in Series A financing to support the development of gene therapies for Parkinson’s disease.

“Networking.” For many people just hearing that word conjures up feelings of dread and anxiety. It’s a form of social and professional interaction – ritual, even – that, while torturous for some, is an absolute necessity in the majority of professional settings and fields, academic and non-academic alike.

U.S. insurer Cigna is acquiring pharmacy benefits manager Express Scripts for approximately $67 billion.

Metactive Medical Inc. announced it has closed an additional $1.2 million in Series A financing from a group of investors, including Mid-America Angels and Serra Ventures, bringing the total funding raised to date more than $10 million.